Robert L. Kunka
Impact in
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
Papers in
-
- Cancer therapeutics and mechanisms 4
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Peter T. Daley‐Yates (3 shared papers)J. A. Robinson (1 shared paper)Susan Andrews (2 shared papers)P. J. Morrison (1 shared paper)Tim Mant (1 shared paper)Glenn Smith (1 shared paper)Theodore R. Bates (2 shared papers)Yongguang Yin (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)British Journal of Cancer (2 papers)Biopharmaceutics & Drug Disposition (2 papers)Pharmaceutical Research (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Robert L. Kunka
20 papers receiving 433 citations
Peers
Comparison fields: 5 of 84
- Immunology and Allergy 45
- Molecular Medicine 28
- Toxicology 19
- Pharmacology 92
- Physiology 131
Countries citing papers authored by Robert L. Kunka
This map shows the geographic impact of Robert L. Kunka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Kunka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Kunka more than expected).
Fields of papers citing papers by Robert L. Kunka
This network shows the impact of papers produced by Robert L. Kunka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Kunka. The network helps show where Robert L. Kunka may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Kunka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 68 | |
| 2 | 2004 | 61 | |
| 3 | 2004 | 38 | |
| 4 | 1996 | 37 | |
| 5 | 1994 | 35 | |
| 6 | Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks. | 1998 | 32 |
| 7 | 2000 | 28 | |
| 8 | 2000 | 26 | |
| 9 | Factors affecting the plasma protein binding of verapamil and norverapamil in man. | 1980 | 23 |
| 10 | 1998 | 20 | |
| 11 | 2011 | 18 | |
| 12 | 1985 | 17 | |
| 13 | 1983 | 15 | |
| 14 | 1984 | 13 | |
| 15 | 1995 | 11 | |
| 16 | 1979 | 10 | |
| 17 | Steady-state fluctuation and variability of betaxolol and atenolol plasma levels. | 1989 | 7 |
| 18 | 1979 | 4 | |
| 19 | 1984 | 3 | |
| 20 | 1995 | 2 |
About Robert L. Kunka
Robert L. Kunka is a scholar working on Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, Analytical Chemistry and Oncology, having authored 20 papers that have together received 468 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Cancer therapeutics and mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Asthma and respiratory diseases (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Immunology and Allergy (45 citations), Molecular Medicine (28 citations), Toxicology (19 citations), Pharmacology (92 citations) and Physiology (131 citations). Robert L. Kunka has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Peter T. Daley‐Yates, J. A. Robinson, Susan Andrews, P. J. Morrison, Tim Mant, Glenn Smith, Theodore R. Bates, Yongguang Yin, Candice Yong and Paul Wissel. Their work appears in journals such as Journal of Pharmaceutical Sciences, British Journal of Cancer, Biopharmaceutics & Drug Disposition, Pharmaceutical Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.